Intra‐Arterial Deoxyribonuclease Therapy Improves Stroke Outcomes in Aged Mice
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70461 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Junxiang Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Aging, Deoxyribonuclease I, Stroke, Ischemic Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Barrow Neurological Foundation, Icahn School of Medicine at Mount Sinai.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Futile recanalization affects more than half of acute ischemic stroke (AIS) patients. Neutrophil extracellular traps (NETs) are a major factor of microvascular hypoperfusion after stroke. Deoxyribonuclease I (DNase) targeting NETs exhibited a neuroprotective effect in young mice with AIS. This study explored a novel direct intra‐arterial administration of DNase therapy and its effect in aged mice with AIS.
Method
AIS was induced in aged C57BL/6 mice followed by reperfusion and immediate, intra‐arterial DNase administration via the internal carotid artery. Cerebral blood flow (CBF), neurological function, cerebral infarct volume, and NET markers were examined.
Results
Direct intra‐arterial DNase therapy significantly increased CBF, reduced neurological deficit scores, increased the latency to fall in the wire hang test, reduced cerebral infarct volume, and decreased neutrophil and NET count in both the parenchyma and micro vessels in aged mice with AIS compared with age‐matched vehicle controls.
Conclusion
Our data is the first to demonstrate that successful, direct intra‐arterial DNase therapy provides more efficient cerebral reperfusion and better outcomes after recanalization during the treatment of large vessel occlusion in aged mice. This study provides evidence for the potential clinical application of catheter‐delivered intra‐arterial DNase therapy post‐recanalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Barrow-ASU Center for Preclinical Imaging, Barrow Neurological Institute, Phoenix, Arizona, USA.
- Colorado School of Mines, Golden, Colorado, USA.
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Junxiang Yin
Förderung
- Barrow Neurological Foundation
- Icahn School of Medicine at Mount Sinai
Zitieren
APA
Yin, J., Wu, M., White, J., StClair, E., Mocco, J., & Waters, M. F. (2025). Intra‐Arterial Deoxyribonuclease Therapy Improves Stroke Outcomes in Aged Mice. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70461
Vancouver
Yin J, Wu M, White J, StClair E, Mocco J, Waters MF. Intra‐Arterial Deoxyribonuclease Therapy Improves Stroke Outcomes in Aged Mice. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70461
BibTeX
@article{Yin2025,
author = {Yin, Junxiang and Wu, Michael and White, Jennifer and StClair, Ellie and Mocco, J and Waters, Michael F},
title = {Intra‐Arterial Deoxyribonuclease Therapy Improves Stroke Outcomes in Aged Mice},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70461}
}
EUVIMED